Association between aflatoxin B1 occupational airway exposure and risk of hepatocellular carcinoma: a case-control study

Tumor Biology

Volumn 35, Issue 10, 2014, Pages 9577-9584

  Lai, Hao ^a   Mo, Xianwei ^a   Yang, Yang ^a   He, Ke ^a   Xiao, Jun ^a   Liu, Chao ^a   Chen, Jiansi ^a   Lin, Yuan ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Aflatoxin B1; Airway exposure; Case control study; Hepatocellular carcinoma

Indexed keywords

AFLATOXIN; AFLATOXIN B1; AFLATOXIN-ALBUMIN ADDUCT; ALBUMINOID; DUST;

ADULT; CASE CONTROL STUDY; DUST; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPOSURE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MANUFACTURING INDUSTRY; MICROBIOLOGY; OCCUPATIONAL EXPOSURE; PAPER; RISK FACTOR; SUGARCANE;

ADULT; AFLATOXIN B1; AFLATOXINS; ALBUMINS; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DUST; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INHALATION EXPOSURE; LIVER NEOPLASMS; MALE; MANUFACTURING INDUSTRY; OCCUPATIONAL EXPOSURE; PAPER; RISK FACTORS; SACCHARUM;

EID: 84922394913     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2231-3     Document Type: Article

References (34)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.
2. Kew MC. Hepatocellular carcinoma in developing countries: prevention, diagnosis and treatment. World J Hepatol. 2012;4:99–104.
3. Qi LN, Li LQ, Chen YY, Chen ZH, Bai T, Xiang BD, et al. Genome-wide and differential proteomic analysis of hepatitis B virus and aflatoxin B1 related hepatocellular carcinoma in Guangxi, China. PLoS One. 2013;8:e83465.
4. Kew MC. Aflatoxins as a cause of hepatocellular carcinoma. J Gastrointest Liver Dis. 2013;22:305–10.
5. Viegas S, Veiga L, Malta-Vacas J, Sabino R, Figueredo P, Almeida A, et al. Occupational exposure to aflatoxin (AFB(1)) in poultry production. J Toxicol Environ Health A. 2012;75:1330–40.
6. Long XD, Yao JG, Huang YZ, Huang XY, Ban FZ, Yao LM, et al. DNA repair gene XRCC7 polymorphisms (rs#7003908 and rs#10109984) and hepatocellular carcinoma related to AFB1 exposure among Guangxi population, China. Hepatol Res. 2011;41:1085–93.
7. Xu L, Qian G, Tang L, Su J, Wang JS. Genetic variations of hepatitis B virus and serum aflatoxin–lysine adduct on high risk of hepatocellular carcinoma in southern Guangxi, China. J Hepatol. 2010;53:671–6.
8. Long XD, Ma Y, Zhou YF, Ma AM, Fu GH. Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population. Hepatology. 2010;52:1301–9.
9. Long XD, Ma Y, Qu DY, Liu YG, Huang ZQ, Huang YZ, et al. The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China. Ann Epidemiol. 2008;18:572–8.
10. Long XD, Ma Y, Zhou YF, Yao JG, Ban FZ, Huang YZ, et al. XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk. BMC Cancer. 2009;9:400.
11. Kensler TW, Egner PA, Wang JB, Zhu YR, Zhang BC, Lu PX, et al. Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas. Gastroenterology. 2004;127:S310–8.
12. Burg WA, Shotwell OL, Saltzman BE. Measurements of airborne aflatoxins during the handling of contaminated corn. Am Ind Hyg Assoc J. 1981;42:1–11.
13. Hamid AS, Tesfamariam IG, Zhang Y, Zhang ZG. Aflatoxin B1-induced hepatocellular carcinoma in developing countries: geographical distribution, mechanism of action and prevention. Oncol Lett. 2013;5:1087–92.
14. Sun G, Wang S, Hu X, Su J, Zhang Y, Xie Y, et al. Co-contamination of aflatoxin B1 and fumonisin B1 in food and human dietary exposure in three areas of China. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2011;28:461–70.
15. Asim M, Sarma MP, Thayumanavan L, Kar P. Role of aflatoxin B1 as a risk for primary liver cancer in north Indian population. Clin Biochem. 2011;44:1235–40.
16. Anitha S, Raghunadharao D, Waliyar F, Sudini H, Parveen M, Rao R, et al. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India. Mutat Res. 2014;766:23–8.
17. Autrup JL, Schmidt J, Seremet T, Autrup H. Determination of exposure to aflatoxins among Danish workers in animal-feed production through the analysis of aflatoxin B1 adducts to serum albumin. Scand J Work Environ Health. 1991;17:436–40.
18. Autrup JL, Schmidt J, Autrup H. Exposure to aflatoxin B1 in animal-feed production plant workers. Environ Health Perspect. 1993;99:195–7.
19. Desai MR, Ghosh S. Occupational exposure to airborne fungi among rice mill workers with special reference to aflatoxin producing A. flavus strains. Ann Agric Environ Med. 2003;10:159–62.
20. Abd-Elaah GA, Soliman AS. Occurrence of fungal species and mycotoxins from decayed sugarcane (Saccharrum officinarum) in Egypt. Mycobiology. 2005;33:77–83.
21. Viegas S, Faisca VM, Dias H, Clerigo A, Carolino E, Viegas C. Occupational exposure to poultry dust and effects on the respiratory system in workers. J Toxicol Environ Health A. 2013;76:230–9.
22. Ghosh SK, Desai MR, Pandya GL, Venkaiah K. Airborne aflatoxin in the grain processing industries in India. Am Ind Hyg Assoc J. 1997;58:583–6.
23. Zhu LR, Thomas PE, Lu G, Reuhl KR, Yang GY, Wang LD, et al. CYP2A13 in human respiratory tissues and lung cancers: an immunohistochemical study with a new peptide-specific antibody. Drug Metab Dispos. 2006;34:1672–6.
24. Zhang Z, Yang X, Wang Y, Wang X, Lu H, Zhang X, et al. Cytochrome P450 2A13 is an efficient enzyme in metabolic activation of aflatoxin G1 in human bronchial epithelial cells. Arch Toxicol. 2013;87:1697–707.
25. Zhang Z, Lu H, Huan F, Meghan C, Yang X, Wang Y, et al. Cytochrome P450 2A13 mediates the neoplastic transformation of human bronchial epithelial cells at a low concentration of aflatoxin B1. Int J Cancer. 2014;134:1539–48.
26. Van Vleet TR, Klein PJ, Coulombe RJ. Metabolism and cytotoxicity of aflatoxin B1 in cytochrome P-450-expressing human lung cells. J Toxicol Environ Health A. 2002;65:853–67.
27. Egner PA, Wang JB, Zhu YR, Zhang BC, Wu Y, Zhang QN, et al. Chlorophyllin intervention reduces aflatoxin–DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci U S A. 2001;98:14601–6.
28. Hu T, Du Q, Ren F, Liang S, Lin D, Li J, et al. Spatial analysis of the home addresses of hospital patients with hepatitis B infection or hepatoma in Shenzhen, China from 2010 to 2012. Int J Environ Res Public Health. 2014;11:3143–55.
29. Wu HC, Santella R. The role of aflatoxins in hepatocellular carcinoma. Hepat Mon. 2012;12:e7238.
30. Qian G, Tang L, Wang F, Guo X, Massey ME, Williams JH, et al. Physiologically based toxicokinetics of serum aflatoxin B1–lysine adduct in F344 rats. Toxicology. 2013;303:147–51.
31. Egner PA, Gange SJ, Dolan PM, Groopman JD, Munoz A, Kensler TW. Levels of aflatoxin–albumin biomarkers in rat plasma are modulated by both long-term and transient interventions with oltipraz. Carcinogenesis. 1995;16:1769–73.
32. Bechtel DH. Molecular dosimetry of hepatic aflatoxin B1–DNA adducts: linear correlation with hepatic cancer risk. Regul Toxicol Pharmacol. 1989;10:74–81.
33. Tang L, Tang M, Xu L, Luo H, Huang T, Yu J, et al. Modulation of aflatoxin biomarkers in human blood and urine by green tea polyphenols intervention. Carcinogenesis. 2008;29:411–7.
34. Qin G, Ning Y, Lotlikar PD. Chemoprevention of aflatoxin B1-initiated and carbon tetrachloride-promoted hepatocarcinogenesis in the rat by green tea. Nutr Cancer. 2000;38:215–22.